Lung Cancer

Latest News

lung cancer
Pembrolizumab Plus Chemotherapy Continues to Display Survival Advantage Over Chemotherapy in NSCLC

March 24th 2023

Patients with metastatic squamous non–small cell lung cancer experienced a clinically meaningful survival benefit when treated with pembrolizumab in combination with chemotherapy.

lung cancer
Patritumab Deruxtecan Makes Headway in Early Phase Trials for Patients With Metastatic EGFR+ NSCLC and HER3+ Breast Cancer

March 21st 2023

Adjuvant Osimertinib Prolongs OS in Early-Stage EGFR-Mutated NSCLC

March 12th 2023

lung cancer
Pembrolizumab Misses Mark in mCRPC, EGFR-Mutant NSCLC Trials

March 5th 2023

FDA Approval
Adjuvant Pembrolizumab Gets FDA Approval in NSCLC

January 26th 2023

Video Series
Video Interviews
Oncology Nursing News
Are Hearing Tests Necessary For Adult Cancer Survivors?
Key Advances in Cancer Survivorship Toxicity Management

More News

© 2023 MJH Life Sciences

All rights reserved.